North America Exosome Research Market: Industry Overview and Forecast (2023-2029)

North America Exosome Research Market Overview:

 

North America Exosome research market is one of the biggest markets among all other regions, with a market size of 66.53 Mn USD in 2021. Therefore, a decent revenue growth is expected over the forecast period because of the granular and tremendous efforts of researchers in the field of exosome in the region. The growing number of research grants and projects of various research organizations are also expected to contribute to North America Exosome research market growth.

 

Projects were undertaken to develop methods that allow for efficient separation and separation of Exosome vesicles. The participation of exosomes in various activities and the existence of a variety of methods are expected to stimulate research in the field, thereby leading to revenue generation. Increased research funding is expected to boost the market in the coming years. This is the major reason why US dominates the North America region market, with a market share of around 58% in 2021.

 

North America Exosome Research Market report examines the market's growth drivers and segments (Conductive Material, Application, End-User, and Region). Data has been provided by market participants and countries (US, Mexico, Canada, Guatemala, Cuba, etc.). This market study takes an in-depth look at all of the significant advancements occurring across all industry sectors. To provide key data analysis for the historical period (2017-2020), statistics, infographics, and presentations are used. The report examines the North America Exosome Research markets, Drivers, Restraints, Opportunities, and Challenges. This SMR report includes North America Exosome Research investor recommendations based on a detailed analysis of the current competitive landscape of the North America Exosome Research market.

COVID-19 Impact on the North America Exosome Research Market:

 

Market volatility, rivalry, and a wide range of worldwide supply chains have all been impacted by Covid-19. Revenue fell in 2020, but it may begin to rise again in 2021. Regional important players who improved their strategy are expected to make a huge leap forward in the race. This pandemic problem highlighted the necessity for more research to enhance the efficiency of Exosome research market in North America. By 2020 and 2021, the halt in experiments and researches as a result of closure and downsizing in all regions is likely to result in a revenue loss for industry participants. Many significant participants are now recovering to pre-COVID production, while productivity in some economies remains low. Almost all-important key players took fast action to modify their performance between the second and third wave estimates.

 

North America Exosome Research Market Dynamics:

 

The development of new platforms and improved technologies is expected to further increase the market growth in the forecast period. The new platforms allow for the acquisition of many proteins in the small membrane and this discovery can be made even after complex plasma proteins.

 

In addition, the role of exosomes in providing diagnostic information for pathological conditions is expected to increase its acceptance in the research field. Exosomes belong to the family of nanovesicles, which perform many functions in diagnosing and treating many diseases.

 

Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle non-viral delivery technology to develop transformative therapeutics, had featured at the 3rd Exosome-Based Therapeutic Development Summit occurring November 16-18, 2021.

 

The presentation highlights new data announced earlier this year on ARMMs pay loading, purification and characterization, including demonstration of cellular uptake and intracellular cargo activity. These results illustrate the ability of Vesigen’s proprietary platform to produce ARMMs in a scalable process and effectively deliver functional payloads. Hence, key players like Vesigen Therapeutics explains the opportunities of the North America exosome research market in the forecast period.

 

North America Exosome Research Market Segment Analysis:

 

By Workflow, In North America region, downstream analysis has been largely in use due to the growing demand for latest technology and downstream analysis processing equipment. Methods of isolation include ultracentrifugation, immunocapture, precipitation, and filtration. Although ultracentrifugation dominated the segment in terms of revenue, other methods are expected to prove a similar growth pattern due to the fragmentary research conducted on segregation agreements. Ultracentrifugation is considered the gold standard of purification. The easy availability of tools and reagents of this method is due to its large market share in North America Exosome research market.

 

Within the downstream analysis phase, flow cytometry dominated the market in terms of revenue due to the high use of this process. The discovery of intelligent solutions and specific agreements of the cytometric method supported the growth of this small group. RNA analysis using NGS and PCR is expected to see significant gains in the coming years due to the increase in the number of platforms installed for NGS analysis.

 

By Application, cancer dominates the entire exosomes research market because of the growing role of exosomes in cancer research. The contribution of exosomes of tumorigenesis, chemotherapeutic resistance, and the development of novel cancer treatments for the identification of cancer biomarkers also contributes to the growth of this market. Exosomes are not only used as a means of drug delivery and chemotherapeutic sensitivity but also as a non-invasive biomarker. This has led to an increase in research and development in these substances.

 

Part of the neurodegenerative disorders provides a significant range of extensions, thanks to the study of exosomes and extracellular vesicles related in the field. Research in this area is important in uncovering the use of exosomes as tools to treat mental disorders and biological symptoms.

 

North America Exosome Research Market Regional Insights:

 

Regionally, North America had the largest share of revenue respectfully in 2021 and this could be due to more support in the U.S. For example, in March 2017, researchers at the Memorial Sloan Kettering Cancer Memorial and Weill Cornell Medicine received two grants from the Sohn Conference Foundation of R&D by classification and classification of tumour-derived exosomes to study the emergence of cancer in children. The above-mentioned instance, clearly reflects the accelerated growth of North America Exosome research market in the North America region. Other North American countries like Canada and Mexico also plays a vital role in the growth of North America Exosome research market.

 

The objective of this report is to present an in-depth analysis of the North America Exosome Research Market to industry stakeholders. The report provides the recent trends in the North America Exosome Research Market and how these factors will impact on new business investment and market enhancement during the forecast period. The report also provides an understanding of the potential of the North America Exosome Research Market and the competitive structure of the market by analyzing market leaders, market fans, and regional players.

 

The quality and quantity data provided in the North America Exosome Research Market report assist the readers to understand which market Conductive Materials, regions are expected to grow in value, market factors, and key opportunity areas, which will impact industry growth and predictable market growth with respect to time. The report includes the competitive status of key competitors in the industry and their recent developments in the North America Exosome Research Market. The report also provides a comprehensive set of factors such as company size, market share, market growth, revenue, production capacity, and profits of key players in the North America Exosome Research Market.

 

 

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the North America Exosome Research Market is easy for a new player to gain an edge in the market, do they come and go in the market regularly if the market is dominated by a few players, etc.

 

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political factors that help in analyzing how much a government can impact the Market. Economic variables assist in the calculating economic performance drivers that can affect the Market. Analyzing the impact of the overall environment and the impact of environmental concerns on the North America Exosome Research Market is aided by legal factors.

 

North America Exosome Research Market Scope:

 

North America Exosome Research Market Scope
Market Size in 2022	USD 117 Mn.
Market Size in 2029	USD 314.8 Mn.
CAGR (2023-2029)	15%
Historic Data	2017-2021
Base Year	2022
Forecast Period	2023-2029
Segment Scope	By Application   Cancer Neurodegenerative diseases
	By  Workflow   Downstream Analysis Isolation Method
Regional Scope	North America- United States, Canada, and Mexico Europe – UK, France, Germany, Italy, Spain, Sweden, Austria, and Rest of Europe Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC Middle East and Africa - South Africa, GCC, Egypt, Nigeria, Rest of the Middle East and Africa South America – Brazil, Argentina, Rest of South America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America Exosome Research Market Key Players

• Thermo Fisher Scientific Inc. (US)
• Danaher (US)
• Illumina Inc. (US)
• Miltenyi Biotec (US)
• MBL International Corporation (US)
• Beckman Coulter Inc. (US)
• Bio-Techne Corporation (US)
• BioVision Inc. (US)
• EverZom (Canada)
• Biocept (Canada)
• B R Cancer Agency (Canada)
• System Biosciences (Canada)
• Premedica (Mexico)
• Powered Research LLC (Mexico)
• Regenstem LLC (US)